{"name":"Desmond Tutu HIV Centre","slug":"desmond-tutu-hiv-centre","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Triphasil","genericName":"Triphasil","slug":"triphasil","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Triphasil","genericName":"Triphasil","slug":"triphasil","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxPRmVzX3ZqamZyOG1sX2tKY1ctTmltSG5TQlBqcWM0cDVNRXhuX3dmOS1nSWk1RjhTYl83aUhKRXkxcENFRm16NHBMaGxNU280aURtNzJvNVEzbjYxajctWEZTVlZqc3dvckZ2d0hRWS1rV0lPUnU0REFNRjdnTDE3SEFiX2pGRWJvN2Uzbm16dUJNZ2t2WUNGckp2akxIVWxnU2Y4THFBd0V2OEtkaWdhYkpUMGk0R0JobThrX3gtVjNvVWhNTkZKWVg5Vm9rejRVQnJZaHZJUFRDZGlma25wbFBoUzlXRlN2WUtmampmQ1BMbXhq?oc=5","date":"2025-10-27","type":"pipeline","source":"Bhekisisa","summary":"SA becomes the first African country to register the twice-a-year anti-HIV jab — at record speed - Bhekisisa","headline":"SA becomes the first African country to register the twice-a-year anti-HIV jab — at record speed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxPUUtLMDl0bEkwOWtIR3I1T091Tl94bVB4XzkwV1EwT2VXT3lCTG90QUVtOUhhT2tqRXcyeUFjT2NrQ0NpbHlWbjZLdG1GTkVZVlN0X3BSenprV1J4aHI1QWxVNVI0SlFqN0s0X1lVU1JXQV94cEZ3a3JvckZFRlJadW9valdrZnpvWkwtTG9pa2h0dUVpNnA2aTR1QTBWUDE1cWV4VmlsM1pwLW44ZHJJajBIUFN4V3ZhOGpjT0g0Y3Fjc0RfRi04RlJwU3NZZThvOVdwa3ZodllMWGl4MkZpU3o1Um1WZw?oc=5","date":"2025-10-01","type":"pipeline","source":"News24","summary":"New twice-a-year anti-HIV jab costs as much as daily prevention pill, set to launch by 2027 - News24","headline":"New twice-a-year anti-HIV jab costs as much as daily prevention pill, set to launch by 2027 - News24","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-15","type":"pipeline","source":"DC News Now","summary":"AG: Pharmaceutical company accused of defrauding DC’s Medicaid program ordered to pay over $300K - DC News Now","headline":"AG: Pharmaceutical company accused of defrauding DC’s Medicaid program ordered to pay over $300K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQM3VSb3ZxTGV4Wm1HdzVzS0VOUWJ5Ymg4WmJDZHlmS3pEMFZPSUlrNEdmUHpTMjhtcTRBMmw1ZThaSU44cjdiVVhfOXhFdlZqT0pndjE2WmZVM0JpOGM0eWl6VFFWazV5LWZ4eEZJc05BWXR0RURCQ0hKelVSanhodHVzOEM2OHpaVENLbWY4ZUxTaDliYURYandsRl9Oc3dzLTVoR0N6SVVyNUJMcUxIcVZqYWRLb3NfYTRfQzZYSzY?oc=5","date":"2025-06-18","type":"regulatory","source":"statnews.com","summary":"HIV protection with just two shots a year: FDA approves Gilead drug - statnews.com","headline":"HIV protection with just two shots a year: FDA approves Gilead drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPdjJEeEFYRFhDZExwQWdZQzFOajJEMUpRekJWbkVZOERKaWhkcXVDR1l2SHFPRll1MDVNN1lYYmJ5OTZra0h1d2VMQ3BGeUNXV3JRVVVFcHc3dWdRM1JpLVhhNXd1OHI0dTh6RDdDR2p1SXBKVnBsUVNIMDFaV19xNFg3N2dGaWFSV0VuSWNGdGh6ejhmYWJqaA?oc=5","date":"2025-05-20","type":"pipeline","source":"Global Health NOW","summary":"U.S. Funding Cuts Stop Crucial HIV Research Work in Its Tracks - Global Health NOW","headline":"U.S. Funding Cuts Stop Crucial HIV Research Work in Its Tracks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQSFlNUmg0VG5rVXFHTzZNVFdRLXV1bmstVDBTQ0RMZUgxUk9mbVJtT1F2RWp3enA3MWd6UllZUHBhaXZseWxYZ3h1V29Mbl95RzhQR21nYUJ0RFduOVpwcVZPNDhvNWRhZ3FuR1hyMml1STVjcXpWWFdZYmxjNlcyQWswaU5EZFF2SWVENTVlWEtiOWhCTlZfVVRxR1FyT09wR2o5NDlkZHZHOEJMUXVpTGxXMA?oc=5","date":"2025-02-18","type":"regulatory","source":"Pharmaceutical Technology","summary":"Gilead’s lenacapavir moves closer to FDA approval for HIV PrEP use - Pharmaceutical Technology","headline":"Gilead’s lenacapavir moves closer to FDA approval for HIV PrEP use","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNRGhSZk9CQlpxNkQxa2dEMThDc3FBRXhaQmd2TlRXZlYzeHhMRkliMWRXcERTY3dYUzEtS3VDc216Yjh0dTZ2cGI5V055U0xYN2owMkZfRENmUjZQMEs0eXl1aUo5S1F0RmRoYXFNaWw3bmlmY2ZtVVBkQ05ORXhaR190by1nRFE4a3VodGd3N2p3TGNEWVE?oc=5","date":"2025-02-05","type":"pipeline","source":"Medical Brief","summary":"Top SA health experts rally to counter Trump’s funding block - Medical Brief","headline":"Top SA health experts rally to counter Trump’s funding block","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNOFkyeElBWWt3bWhFcjZQakhTOEw5bmhmdGVoYW9wTXY3NW9pMEVQZ2poRE5YdjhYemdoM2RaX1VpcUo3ZlNISWxuR0pLUVJfUTZ1UEFGOFBFMmsyTmlsaDRmNEhDSHJHZlhzelVNT3J6NWFlMDVUOGVuZmFrMzh4QUtGNmx1SUFGNFJuNVowcjRxM0FSV19EbkNCdEt2MDM1M2p1a0IyNl8?oc=5","date":"2024-06-24","type":"trial","source":"healthpolicy-watch.news","summary":"Gilead Urged to Prioritise Access as Injection Trial Proves 100% Successful in Preventing HIV - healthpolicy-watch.news","headline":"Gilead Urged to Prioritise Access as Injection Trial Proves 100% Successful in Preventing HIV - healthpolicy","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQQVBwTWRBUEVWTnVpdklMRkQ3UGpiT2lzc2NOV1BKQzFXOG9MYW9LcnFxeE5sQmhfZkgwVzlDTVJ6dW41Yl9sSFZsenlISXdxd3dQZ3JMMGxYSjdhNTNUZHcwdVhBU2xkQlRnaUFmMkEteWlTUUJVTEY3bzAyYW1GdWhXcWdmQXloVWlPSQ?oc=5","date":"2024-06-21","type":"trial","source":"pharmaphorum","summary":"Gilead’s twice-yearly HIV PrEP 100% effective, says study - pharmaphorum","headline":"Gilead’s twice-yearly HIV PrEP 100% effective, says study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNV09QVUwta2w3Rmt5dE0wSXNKT0VqU09rSVhZTFBMYkJIa3ZJQzlvYkVFaXIxWDJvY0pqcngwb00yX3o0dDNaRlJMSzZZYjBiSVRJcDF3VjNLQnBCX2FnTlBXLVpUcnF1VlFIZ2pZal84aGRnckpWWUxqbW9xOWh1VEd1bjBYRlpHdEthNGJwMnZTZkQyYUw2T0JqY2RvaU1rWGRLdS1vSXNWQU42UnNzUEdfckM?oc=5","date":"2024-06-20","type":"pipeline","source":"Fierce Pharma","summary":"Watch out, GSK. Gilead’s twice-yearly PrEP drug shows 100% efficacy for HIV prevention - Fierce Pharma","headline":"Watch out, GSK. Gilead’s twice-yearly PrEP drug shows 100% efficacy for HIV prevention","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxOUFNEbUl1bmh1NVpSUm4tcDFtektDdDJNdUtrXzRob21CU05TQUxjWkppMERMTDUtNlNjNnB3bkw1QTF2SVRWTHp4TlBSNXlIejN6MXc2b3RBOGVUNkhRaWpPX2V0VWZQRGFHTS0tc2JCYzREZmtnLU9Kbm1NZXpYU1lWY9IBhgFBVV95cUxPdVdaNlVxdHBpa0VrUzJnUGFYN0lWelNwVkp4RWlVUUxKaVF2WWNrVXcxbUFRcTVVWjc4Yy1neEViazNqMzh5eFFUaXNxU0hYa2Nham9td201bEo5bzhfei1HdGgzUHNtQmxfZGp2UjRXUHMxVGoyeWtaNno0TWlmc0dCc3RIQQ?oc=5","date":"2022-12-01","type":"pipeline","source":"VOA Africa","summary":"South Africa Advances AIDS Treatment - VOA Africa","headline":"South Africa Advances AIDS Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPbUJwWTdTVW42UHVuOVVkeGRsZUpqQ0ZOU1BHenEzeFl3ZTAtOGVXT013SUY0NnhqSlJpUDNPMUpsQlA1ZEhpYS15Qi1iUHZYMkphZ0c4ZVAwcnFuODBfeDhkdjg0S1JiMENoOV9yWi1qUjhpek9kRzV6NmpMUzRHc1FqOXBfR2FEX0tGZllnNnBqVXJHc1hkamFxZFFPMUhEMXlIVFlxZ0kweDVOWk1ZazBCVmg?oc=5","date":"2022-06-05","type":"pipeline","source":"BioSpectrum Asia","summary":"Podcast : The injustice of disease burden and access to vaccines - BioSpectrum Asia","headline":"Podcast : The injustice of disease burden and access to vaccines","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}